Celltrion USA is a science-led, patient-focused organization building what's next in medical science.

We put patients at the center and back it up with rigorous science and end-to-end capabilities—from research through reliable supply and access—so more people can get access to care.

Our history of building what's next

Headquartered in Jersey City, New Jersey, we carry Celltrion's global legacy of research, development, and accessibility into every medicine we deliver.

Discover our origins

Aspiring to what's next in patient care

From next-generation antibodies and antibody-drug conjugates to biosimilars and microbiome-based therapies, our pipeline is designed to move medicine forward. Explore how Celltrion is developing treatments in oncology, immunology, and beyond—built on science, shaped for patients.

Explore the pipeline

Celltrion is here to support you every step of the way

Starting treatment can feel overwhelming—but you don’t have to do it alone. Our support programs are here to guide you, from understanding your coverage and co-pay options to getting your medication.

Find help here

Together with us

Our partnerships are built around one goal: better outcomes for patients.

Learn how

Build the future with us

Explore career opportunities that challenge you, inspire you, and push the boundaries of what’s possible.

Take the next step

Latest Press Releases

Celltrion to present seven abstracts in inflammatory bowel disease (IBD) at 2026 Digestive Disease Week® (DDW)

Read more

Celltrion announces U.S. availability of AVTOZMA® (tocilizumab-anoh) subcutaneous (SC) formulation

Read more